Previously, we identified PHR1 as an abundantly expressed gene in photoreceptors and showed that it encodes four isoforms, each with N-terminal pleckstrin homology (PH) and C-terminal transmembrane domains. To better understand PHR1 function and expression, we made a Phr1 null mouse by inserting a ␤-galactosidase/neo r cassette into exon 3. In addition to photoreceptors, we found abundant expression of specific Phr1 splice forms in olfactory receptor neurons and vestibular and cochlear hair cells. We also found Phr1 expression in cells with a possible sensory function, including peripheral retinal ganglion cells, cochlear interdental cells, and neurons of the circumventricular organ. Despite this discrete expression in known and putative sensory neurons, mice lacking PHR1 do not have overt sensory deficits.
Previously, we identified PHR1 as an abundantly expressed gene in photoreceptors and showed that it encodes four isoforms, each with N-terminal pleckstrin homology (PH) and C-terminal transmembrane domains. To better understand PHR1 function and expression, we made a Phr1 null mouse by inserting a ␤-galactosidase/neo r cassette into exon 3. In addition to photoreceptors, we found abundant expression of specific Phr1 splice forms in olfactory receptor neurons and vestibular and cochlear hair cells. We also found Phr1 expression in cells with a possible sensory function, including peripheral retinal ganglion cells, cochlear interdental cells, and neurons of the circumventricular organ. Despite this discrete expression in known and putative sensory neurons, mice lacking PHR1 do not have overt sensory deficits.
To clone genes exclusively or preferentially expressed in retina, our investigators performed a differential hybridization screen of an arrayed human retinal cDNA library (38, 39) . Among the several genes identified, we focused on one, PHR1, which we found to be highly expressed in retina and brain. Our group showed that in humans and mice, PHR1 uses two promoters and alternative splicing of an internal exon to produce four transcripts in a tissue-specific manner (46) . The PHR1 5Ј promoter appeared to be photoreceptor specific, controlling the expression of transcripts 1 and 2, which differ only by the presence (transcript 1) or absence (transcript 2) of the alternatively spliced exon 7. A second PHR1 promoter in intron 2 directs expression of transcripts 3 and 4, both encoding proteins lacking the N-terminal 19 amino acids of the products of transcripts 1 and 2 and containing or lacking the sequence encoded by exon 7, respectively. All four PHR1 isoforms have a pleckstrin homology (PH) domain at their N terminus and a transmembrane domain at their C terminus. In the retina, PHR1 is an abundant integral membrane protein in the outer segments of the photoreceptors. Using in vitro binding assays, our investigators showed that the PH domain of PHR1 does not bind any of several inositol phosphates (IP), including 1-IP, 1,4-IP2, 1,4,5-IP3, and 1,3,4,5-IP4, nor several phosphatidylinositol phosphates (PIPs), but it does exhibit specific binding to transducin ␤␥ subunits (46) . On the basis of these results, our group suggested that PHR1 might play a role in modifying signal transduction in the photoreceptors.
PH domains are compact protein modules formed by sequences of 100 to 120 amino acids (17, 24, 29, 32, 36) . Despite only 10 to 30% sequence identity, they have a common tertiary structure (8, (23) (24) (25) . The N-terminal sequence comprises seven antiparallel ␤-strands, with the first four and the last three arranged in two ␤-sheets, oriented with respect to each other at an angle of about 60°, forming a ␤-sandwich structure. The C-terminal sequence of the PH domain forms an ␣-helix that folds over and "closes off" the wider end of the ␤-sandwich (8, 36) . Proteins containing PH domains participate in cellular signaling, cytoskeleton organization, and other processes (23, 25, 28) and are found in a wide variety of species, from yeast to mammals. In Saccharomyces cerevisiae, there are 27 PH domain-containing proteins, while the draft human genome sequence has 252 different human proteins containing at least one PH domain, making it the 11th most common motif in the human proteome (19, 25) . Although the function of most PH domains is uncertain, several have been shown to mediate reversible association of their host protein to cellular membranes binding PIPs and/or G␤␥ subunits on the membrane (21, 24, 28, 35) . In this regard, PHR1 is atypical in two ways. First, with its C-terminal transmembrane domain, PHR1 appears to be integrated into the membrane by a mechanism independent of its PH domain. As far as we know, PHR1 is the only integral membrane protein containing a PH domain. Second, despite extensive in vitro binding studies, neither we (46; S. Xu and D. Valle, unpublished data) nor others (22) have been able to identify binding of the PH domain of PHR1 to PIPs or IPs.
Other groups using different nomenclature have also reported studies of PHR1 (3, 22) . Krappa et al. identified PHR1 and a homolog with 40% amino acid identity, PHR2, which they designated evectin 1 and 2, respectively (22) . RNA blotting showed high expression of Phr1 in retina and brain, with more general expression of Phr2. In situ hybridization suggested that Phr1 expression was prominent in photoreceptors, oligodendrocytes, and Schwann cells. Based on this expression pattern and the results of a pulse-labeling experiment in iso-lated frog photoreceptors, Krappa et al. suggested that PHR1 was a mediator of post-Golgi protein trafficking in cells that produce large amounts of membrane. Andrews et al. identified PHR1, which they designated KPL1, as a gene whose expression increased dramatically when rat tracheal epithelial cells were grown under conditions that stimulate ciliogenesis (3) . RNA blotting showed the highest expression in the brain, with lower but detectable levels in liver, spleen, trachea, and lung (the retina was not tested).
To extend our studies of PHR1 expression and function, we produced a Phr1 knockout-knockin mouse, disrupting expression of Phr1 and introducing a ␤-galactosidase (␤-Gal) gene downstream of the Phr1 promoters. Here, we describe the cellular expression pattern of Phr1 by using 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) histochemistry and phenotypic studies on Phr1 ␤-Gal/␤-Gal mice.
MATERIALS AND METHODS

Phr1 targeting construct.
We cloned and sequenced a 10.6-kb segment (AF071001) of the murine Phr1 structural gene extending from 1.3 kb 5Ј of the transcription start site to intron 6 containing two HindIII fragments, a 5Ј 7.5-kb and a 3Ј 3.1-kb fragment (subclones pH7.5 and pH3.1 in pBluescript [BioCrest/ Stratagene, Cedar Creek, Tex.]). To create the 5Ј arm of the construct, we made a primer (ClaI F) by creating a ClaI site, 5Ј-TTGAGACTCATCGATAGACT GAGACA-3Ј, corresponding to sequence about 3.1 kb 5Ј of exon 3 and amplified with a reverse primer imperfectly complementary to exon 3, and by creating a XhoI site (KO-4, 5Ј-GCCCCTCTCGAGGGCCATTTCT). We made a forward primer, KO-3, complementary to primer KO-4, containing the XhoI site (5Ј-G AAATGGCCCTCGAGAGGGGCG-3Ј). Using KO-3 and the T7 primer of the vector of H7.5, we amplified a modified fragment containing exon 3 with an XhoI site on the 5Ј end and the 3Ј HindIII site of the clone pH7.5 at its 3Ј end. Using the introduced restriction sites, we ligated and cloned the two amplified fragments as a single fragment with an engineered XhoI site at the targeting site in exon 3 in a pBK-CMV (ClaI/HindIII) vector (BioCrest/Stratagene). To develop the 3Ј arm of the construct, we designed a reverse primer, KO-2 (5Ј-AGTTAT CCGAATTCAGCTGGGGAG-3Ј), creating an EcoRI site, about 700 bp into intron 5. Using KO-2 and the vector T3 primer of pH 3.1, we amplified a modified fragment, extending from the 3Ј end of intron 3 to intron 5, with an EcoRI site corresponding to sequence at the 3Ј end. We cloned this HindIII/ EcoRI fragment into pBK-CMV. Using a ClaI/HindIII double digestion, we released the left arm and ligated it to the right arm to produce the construct pKO-10. We obtained a ␤-Gal/neo r cassette plasmid, ploxpSA␤galneo (modified from pSA␤gal, a gift from S. Cole and R. Reeves, Johns Hopkins University School of Medicine, Baltimore, Md.) (11, 12) . We released the ␤-Gal/neo r cassette with XhoI digestion and ligated it into the XhoI site of KO-10 to produce the finished targeting construct, pKO-12.
ES cells, homologous recombination, and blastocyst injections. We transfected R1 cells (from J. Rossant, Mount Sinai Hospital, Toronto, Ontario, Canada) and J-1 cells (from A. Lawler, Johns Hopkins University School of Medicine) with ϳ30 g of the AsuII-linearized pPhr1KO-12-␤-gal by electroporation (Gene Pulser; Bio-Rad, Melville, N.Y.) in two separate experiments. We selected G418-resistant embryonic stem (ES) cell colonies as described elsewhere (44) . We picked 302 colonies and screened them for homologous recombination by digesting the DNA with BclI and hybridizing Southern blots with the indicated 5Ј and 3Ј probes. The 5Ј probe was a 757-bp genomic fragment covering Phr1 exon 1 and exon 2 amplified with the forward primer H7.5-6 (5ЈCAGAG AATGAGTTAAAGGCAC-3Ј) and reverse primer H7.5-8 (5Ј-GTCGCTACTT TGACTAGCTC-3Ј). This probe detects an 8.0-kb fragment in the targeted allele and a 9.5-kb fragment in the wild-type allele. The 3Ј probe was a 258-bp genomic fragment complementary to exon 6 amplified with a forward primer, KO-1 (5Ј-CTCCCCAGCTGAATTCGGATAACT-3Ј), and reverse primer, M-R-14 (5Ј-GTGGAATTTGCCTCCATCAG-3Ј). This probe detects a 3.5-kb fragment in targeted alleles and a 9.5-kb fragment in the wild-type allele. Two ES cell clones, one from the R1 cells (1E7) and one from J-1 cells (II-C-12), demonstrated homologous recombination. We injected cells from each clone into C57BL/6J blastocysts to produce two lines of chimeric mice in the Transgenic Facility of the Johns Hopkins University School of Medicine. For the studies reported here, we used mice derived from the 1E7 clone. We obtained similar expression and phenotypic results in mice derived from the II-C-12 clone (data not shown).
Breeding and manipulation of knockout mice. We identified male chimeric mice by coat color and bred them to female C57BL/6J mice (Jackson Labs, Bar Harbor, Maine) to generate mice heterozygous for the targeted Phr1 gene (F 1 ) and bred these to produce homozygotes. All animal breeding and manipulations were carried out according to National Institutes of Health guidelines at the Johns Hopkins University School of Medicine.
DNA preparation and genotyping. We followed the protocol described by Wang et al. (42) for mouse tail genomic DNA extraction. Genotyping was performed either by Southern blot hybridization as described above or by PCR. For the PCR assay, the wild-type allele was amplified with H7.5-23 and H7.5-2 (H7.5-23, 5Ј-GCAGGAGCAGAGCCTTAGG-3Ј; H7.5-2, 5Ј-AGGCCAACTA GGGCTACATG-3Ј), producing a 794-bp fragment; the targeted allele with H7.5-23/galneo-1 (galneo-1, 5Ј-TCATCAAGCTTATCGATACCG-3Ј) produced a 474-bp product. The PCR conditions were 95°C for 30 s, 60°C for 60 s, and 70°C for 60 s for 30 cycles.
␤-Gal staining. We used a protocol described by Mombaerts et 6 , 1 mg of X-Gal/ml] at 37°C for 2 h to overnight. After staining, the tissue was incubated in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 1 h and washed with 1ϫ PBS to complete the fixation.
Tissue sections affixed to glass slides were incubated in 4% paraformaldehyde for 10 min at room temperature, washed three times with 1ϫ PBS plus (PBS plus 2 mM MgCl 2 ), and stained in buffer C at 37°C for 2 h to overnight. The sections were then postfixed with 4% paraformaldehyde for 10 min before mounting coverslips. Where indicated, sections were counterstained with hematoxylineosin or eosin alone.
ERG recordings. Mouse electroretinograms (ERGs) were obtained with an EPIC-2000 system (LKC Technologies Inc., Gaithersburg, Md.) as described previously (43) .
Single-cell electrophysiology of rod photoreceptors. Single-cell electrophysiology was as described by Yang et al. (47) . Briefly, the mice were dark adapted overnight and killed by CO 2 asphyxiation under dim red light. All subsequent procedures were performed under infrared light. The retina was isolated from the enucleated eye in chilled, oxygenated Leibovitz's L-15 medium (Invitrogen, Grand Island, N.Y.) and placed photoreceptor-side up on a glass capillary array (10-m-diameter capillaries; Galileo Electro-Optics, Sturbridge, Mass.) on which the retina was held by suction, allowing the vitreous humor to be removed by slicing with a razor blade between the retina and the array. The retinal pieces were stored in L-15 medium on ice until use. When needed, a piece of retina was chopped under L-15 medium containing 8 g of DNase (Sigma Chemical, St. Louis, Mo.)/ml with a razor blade mounted on a lever arm, and a suspension of small retinal fragments was transferred into the recording chamber. The chamber temperature was held at 36 to 38°C by continuously perfusing it with heated solution buffered with bicarbonate and bubbled with 95% O 2 -5% CO 2 , pH 7.4. The outer segment of an isolated rod or a rod projecting from a small fragment of retina was drawn into a suction electrode connected to a current-to-voltage converter. The recorded membrane current was filtered with a low-pass, eightpole Bessel filter at 30 Hz and digitized.
The suction electrode was filled with a solution containing (in mM): 134.5 Na
succinate, 3 L-glutamate, 10 glucose, 10 HEPES, and 0.02 EDTA plus basal medium Eagle amino acid supplement and vitamin supplement (Invitrogen). The perfusion medium was the same except that 20 mM NaHCO 3 replaced an equimolar amount of NaCl.
Auditory brain stem responses (ABR).
Using anesthetized mice, we placed electrodes at the vertex (active), bilaterally in the neighborhood of the postauricular bullae, and in the forehead (ground) as described by Xiang et al. (45) . The acoustic stimulus consisted of a click of approximately 0.1 ms in duration at a rate of 11.4 per s. Responses were averaged over 1,000 stimuli. Auditory thresholds were determined by visual inspection of response traces obtained at stimulus intervals of 5 dB. Absolute stimulus intensities were calibrated to obtain the sound pressure level. EOG recordings. We followed the protocol described by Zhao et al. M dimethyl sulfoxide was diluted to the indicated concentration in water. The diluted solution (2 ml) was placed in a 10-ml glass test tube about 2 h before the experiments to allow the odorant to equilibrate in the vapor phase. The vapor was delivered as a 0.1-s pulse into a continuous stream of humidified air flowing over the tissue surface. The EOGs were initially recorded using amyl acetate as odorant at 10 Ϫ6 , 10 Ϫ5 , 10 Ϫ4 , and 10 Ϫ3 M. Five additional odorants (carvone, cineole, citral, hexanal, and heptanol) were tested at 10 Ϫ4 M. The magnitudes of the EOG responses were normalized to the response to 10 Ϫ4 M amyl acetate measured at the beginning, midpoint, and completion of the experiment. This response declined by less than 10% over the course of the experiment.
Tyrosine hydroxylase detection. As described by Baker et al. (4), we perfused anesthetized mice with 1ϫ PBS for 5 min followed by 4% paraformaldehyde for 20 min and then removed and fixed the brain with 4% paraformaldehyde for another 2 h. After washing with 1ϫ PBS, the brain was transferred to 30% sucrose in PBS overnight and then embedded in OCT (Tissue-Tek). We made coronal sections at 15 to 20 m. The tyrosine hydroxylase was detected by rabbit anti-tyrosine hydroxylase polyclonal antibody (1:500; Chemicon, Temecula, Calif.) as primary antibody and biotinylated goat anti-rabbit immunoglobulin G as secondary antibody (1:200) in the Vectastain and DAB system (Vector, Burlingame, Calif.) according to the manufacturer's instructions.
RESULTS
The Phr1 targeting construct. We utilized a 7-kb fragment of the Phr1 structural gene to assemble a targeting construct with a ␤-Gal/neo r cassette inserted into exon 3 following the L22 codon (Fig. 1) . The initiation methionine (M1) for photoreceptor-specific PHR1 isoforms is encoded in exon 2. A second methionine, M20, serves as the initiator for isoforms 3 and 4. Thus, insertion of the ␤-Gal/neo r cassette following the L22 codon disrupts all four PHR1 isoforms and would be anticipated to bring the introduced ␤-Gal gene under the control of the native retina-and brain-specific Phr1 promoters. The next in-frame Phr1 methionine codon is M121. Initiation at this position would delete the N-terminal half of PHR1, including the PH domain. The ␤-Gal cassette has its own translation initiation site, 266 bp downstream of its 5Ј end.
Phr1 is highly expressed in primary sensory neurons. We found intense ␤-Gal staining in the photoreceptors of Phr1
and Phr1 ␤-Gal/␤-Gal animals and in some cells in the retinal ganglion cell layer (Fig. 2) . There was no staining in pigment epithelium (data not shown). The agreement of these results with those of our previous in situ hybridization and immunohistochemical studies indicates that ␤-Gal expression from the targeted Phr1 allele recapitulates the normal Phr1 expression pattern (46) . Interestingly, the pattern of ␤-Gal staining in the ganglion cell layer confirmed our impression from previous studies that not all cells in this layer express Phr1. To examine this in more detail, we stained retinal whole mounts and serial sections and found that the Phr1-expressing cells in the ganglion cell layer were greatly enriched in the peripheral retina and virtually absent in the central retina (Fig. 2C to F) .
Unexpectedly, we also found that the olfactory epithelium (OE) and the olfactory bulb displayed intense ␤-Gal staining in Phr1 ␤-Gal/ϩ and Phr1 ␤-Gal/␤-Gal animals (Fig. 3) . All three patches of sensory epithelium in the nasal cavity, the major olfactory epithelium, the vomeronasal organ, and the septal organ of Masera, stained for ␤-Gal, as did most of the glomeruli and nerve fibers in both the main and accessory olfactory bulbs. The OE did not stain in control Phr1 ϩ/ϩ animals (data not shown), nor was there staining of respiratory epithelium in the Phr1 ␤-Gal/ϩ animals (Fig. 3G) . Thus, Phr1 is expressed in the ciliated primary sensory epithelium but not in the ciliated respiratory epithelium of the naso-pharynx.
To confirm expression of Phr1 in the OE, we stained sections of the nasal cavity with anti-PHR1 antibody (Fig. 3C to F) and isolated RNA and protein from these tissues for RNA and immunoblot analysis (Fig. 4) . The immunohistochemistry showed that PHR1 is present in the cell bodies and knobs of the mature olfactory receptor neurons (Fig. 3E and F) . Northern blot analysis of RNA isolated from the OE showed that Phr1 mRNA was present in amounts that exceeded those in retina and that by size were transcript 3 or 4 (Fig. 4) . Reverse transcription-PCR (RT-PCR) with Phr1 splice form-specific primers showed that transcript 4, driven by the internal promoter and lacking exon 7, is the major Phr1 transcript in OE (Fig. 4B) . This result was consistent with immunoblotting studies showing that the short isoform of PHR1 was predominant in the OE (Fig. 4C) .
These results in photoreceptors and OE suggested that Phr1 might also be expressed in other sensory neurons. Using whole-mount staining of the inner ear of Phr1 ␤-Gal/ϩ and Phr1 ␤-Gal/␤-Gal mice, we found strong ␤-Gal staining of the hair cells of the sensory epithelium of the cochlea and the vestibular organs, including the utricle, saccule, and ampullae (Fig. 5) .
RT-PCR of RNA isolated from Phr1 ϩ/ϩ inner ears confirmed Phr1 expression and showed that, as in the OE, Phr1 transcript 4 was predominant (data not shown). In cochlea, we also observed ␤-Gal staining of interdental cells at the surface of the spiral limbus facing the endolymph in the cochlear duct (Fig.  5C) . Here, intensely staining interdental cells were intermixed with a similar number of nonstaining interdental cells (Fig.  5E) .
In brain, we found Phr1 expression in the pineal gland and in most, if not all, of the circumventricular organs (CVO), including the subfornical organ, subcommissural organ (SCO), and the organum vasculosum lamina terminalis (Fig. 6) . Neurons in the CVO are thought to detect circulating peptide hormones, neuropeptides, and chemokines, as well as sensing changes in the osmotic pressure of the extracellular fluid (7, 16, 37) . Thus, expression of Phr1 in these cells is consistent with its expression in primary sensory neurons. We also noted ␤-Gal staining in a few unidentified cells in the thalamus, hypothalamus, and other regions of the brain (data not shown). In contrast to the observations of Krappa et al. (22), we found no prominent staining in regions rich in oligodendrocytes.
We also searched for ␤-Gal staining in taste buds and in the dorsal root ganglia. In tongue, we observed an occasional strongly stained taste bud, but most had no detectable staining (see the appendix, Fig. A1A to D) . In contrast, the stretch receptors on the neuromuscular spindles of tongue muscle fibers were uniformly stained (see Fig. A1E and F). These structures have two or more myelinated afferent fibers entering each spindle and detect alterations in tension on the neuromuscular spindle (34) . We also observed a few positive cells in the epithelia of the epiglottis, pharynx, and larynx that may represent sensory neurons in these areas (data not shown). In the dorsal roots, there was low but detectable staining of the axons but not the cell bodies, while there was no detectable staining in the ventral roots (see Fig. A1G to I ). This modest ␤-Gal staining in the dorsal but not the ventral roots suggested low-level Phr1 expression in the sensory neurons. The Phr1 ␤-gal allele is a null. Using RNA blotting or RT-PCR on total cellular RNA and immunoblot analyses of protein extracts from retina, OE, inner ear, and brain, we found no expression of Phr1 transcript or protein in Phr1 ␤-Gal/␤-Gal mice (Fig. 4) . Thus, the targeted Phr1 allele is a null at both the mRNA and protein levels. We did detect a faintly hybridizing, smaller (ϳ1.5-kb) transcript in total cellular RNA isolated from the OE of both Phr1 ␤-Gal/␤-Gal and Phr1 ϩ/ϩ mice (Fig.  4A) . Because this was present in animals of both genotypes and because we did not detect this transcript in RT-PCR experiments with primers complementary to the Phr1 open reading frame, we conclude that it represents a cross-hybridizing transcript that does not originate from the Phr1 locus.
Phenotypic assessment of Phr1
␤-Gal/␤-Gal
mice. The Phr1
␤-Gal/␤-Gal mice appeared normal at birth without obvious malformations or behavioral or growth abnormalities. The genotype of offspring of heterozygous matings fit Mendelian expectations. At ages 6 months and 1 year, we performed phenotypic studies focusing on the sensory systems with high Phr1 expression and using Phr1 ϩ/ϩ littermates as controls. Retinal histology and ERGs were normal, as were recordings of single rod photoreceptor recordings of cells isolated from a 2-monthold animal ( Fig. 7 ; see also and tyrosine hydroxylase staining of the olfactory bulb, a neurotransmitter biosynthetic marker in the olfactory system (4), and EOG recordings were normal ( Fig. 7 ; see also Fig. A3A to H). Also, rotorod tests for balance (data not shown), inner ear histology, and ABR were normal ( Fig. 7 ; see also Fig. A4) . Moreover, as a test of functions mediated by receptors in the CVO, we subjected 6-month-old Phr1 ␤-Gal/␤-Gal animals to a water deprivation test (30, 40) . Their response as measured by changes in weight and water consumption at the end of 48 h without water was indistinguishable from that of controls (data not shown). Serum and urine electrolyte concentrations in animals eating and drinking ad libitum were also indistinguishable from those of controls (see Fig. A5 ).
Expression of Phr2 in Phr1
␤-Gal/␤-Gal mice. One possible explanation for the apparent lack of a phenotype in animals homozygous for targeted disruption of a specific gene is compensatory expression of another gene encoding a protein whose function is similar to that of the deficient protein. Phr2 is an obvious candidate suppressor of the phenotype in the Phr1 ␤-Gal/␤-Gal animals. Northern blotting of RNA from retina, OE, and brain, however, showed at most a modest increase in expression of Phr2 (Fig. 8) . Using densitometry to quantitate the level of Phr2 expression by Northern blot analysis, we found the ratio of PHR2 to actin in brain RNA was 0.13 Ϯ 0.02 (mean Ϯ standard deviation) in wild-type animals (n ϭ 4) and 0.16 Ϯ 0.02 in Phr1
␤-Gal/␤-Gal animals (n ϭ 4) (ϩ23%), while in retina RNA it was 0.23 Ϯ 0.06 in wild-type animals (n ϭ 2) and 0.29 Ϯ 0.06 in Phr1
␤-Gal/␤-Gal animals (n ϭ 4) (ϩ26%).
DISCUSSION
Evolution has produced many types of sensory neurons, each with unique structural and biochemical properties specifically suited for their function. Using a ␤-Gal reporter gene, we found that Phr1 is highly expressed in several of these highly specialized cells. In agreement with our previously published in situ hybridization and immunohistochemistry results (46), we observed strong ␤-Gal activity in the rod and cone photoreceptors, pineal body, and in some cells in the retinal ganglion cell layer of Phr1 ␤-Gal mice. This result indicates that the expression patterns of Phr1 are preserved in our Phr1 ␤-Gal mouse. In addition to these previously identified sites of Phr1 expression, we also found strong Phr1 expression in the receptor neurons of the OE and in the hair cells of the sensory epithelia of the inner ear. We confirmed the expression of Phr1 in these tissues by immunohistochemistry, RNA blotting, and RT-PCR studies. Our results in the inner ear were consistent with the recent report listing PHR1 among 52 genes preferentially expressed in the inner ear compared to a pool of mRNAs isolated from 29 other tissues (not including retina or OE) (1) .
The major Phr1 transcript in the OE and inner ear is transcript 4, driven by the internal promoter and lacking exon 7, while in photoreceptors, transcripts 1 and 2 predominate. The latter is consistent with our group's previous conclusion that transcripts 1 and 2 are photoreceptor specific and expressed under the control of the 5Ј or photoreceptor-specific Phr1 promoter. This promoter contains multiple copies of the TA ATCC/A sequence recognized by CRX, a homeobox transcription factor whose expression is limited to photoreceptors and whose activity is necessary for photoreceptor development and function (13, 14, 46) . Recent serial analysis of gene expression studies in the retina of mice with targeted disruption of Crx have shown that Phr1 expression is dependent on this transcription factor (6) .
We also found ␤-Gal staining evidence for low-level Phr1 expression in dorsal root neurons, the stretch receptors of the tongue musculature, and in the neurons of at least a few taste receptors. These results indicate that Phr1 is expressed in many if not all of the classical sensory neurons, including those that utilize G-protein-coupled signal transduction systems (photoreceptors, OE, and taste receptors) and those that utilize a G-protein-independent transduction system (hair cells of the inner ear). These observations suggest that, despite our earlier in vitro observation of PHR1 binding to the ␤␥ subunit of transducin, the function of PHR1 is something other than a modulator of G-protein-coupled signal transduction processes. Moreover, because the Phr1 ␤-Gal/␤-Gal animals did not manifest an overt phenotype at up to 1 year in age, PHR1 function clearly is not vital for sensory neuron survival.
Expression of Phr1 in cells other than classical sensory neurons is also of interest. In the retina some, but not all, cells in the ganglion cell layer express Phr1. There is a gradient of Phr1-expressing cells in the ganglion cell layer, increasing from nearly none in the central retina to nearly all in the peripheral retina (Fig. 2) . In mouse retina, 40% of the cells in the ganglion cell layer are ganglion cells; most of the remainder are displaced amacrine cells (20) . The density of ganglion cells decreases from central to peripheral retina (20) , in a distribution inverse to that of the Phr1-expressing cells. This suggests that Phr1 expression marks a distinct cell type in the ganglion cell layer. In mammals, cells preferentially located in the peripheral ganglion cell layer include special melanopsin-containing photosensitive ganglion cells, whose function is necessary for entrainment of circadian rhythms (5, 9, 10, 18, 27) . Given their overlapping distribution in the ganglion cell layer and the association of Phr1 expression with sensory neurons, it is tempting to speculate that the Phr1-expressing cells in the peripheral ganglion cell layer include the photosensitive ganglion cells; however, the density of these cells appears to be lower than those expressing Phr1 (18) . Additional studies comparing the location of cells expressing melanopsin and PHR1 and the circadian behavior of Phr1 ␤-Gal/␤-Gal mice will be necessary to clarify this issue.
In the organ of Corti, we found Phr1 expression not only in the inner and outer hair cells, but also in a subset of interdental cells ( Fig. 5C and E) . These cells are long, spindle-shaped cells, We also found specific Phr1 expression in cells comprising the CVO of the mouse brain, including the pineal body, subfornical organ, organum vasculosum lamina terminalis, and SCO (Fig. 6 ). These cells are thought to provide an important link between the brain and the peripheral metabolic and endocrine systems (15) . The CVOs are specialized structures near the surface of the third and fourth cerebral ventricle that are highly vascularized with special fenestrated capillaries (34) . With the exception of the SCO, all CVOs lack a blood-brain barrier (34) and all have extensive afferent and efferent neural connections and a distinctive cytoarchitecture (33) . Moreover, several peptide hormones, including angiotensin II, somatostatin, relaxin, leutinizing hormone releasing hormone, oxytocin, and vasopressin and their receptors have been detected in CVOs. For example, Liedtke et al. recently identified the vanilloid receptor-related osmotically activated channels expressed in the CVO neurons (26) . These observations have lead to the hypothesis that the CVO contains special sensory neurons involved in osmoresponsive pathways, the baroreflexes, and in the control of food intake and salt and water homeostasis (15, 37) . Expression of Phr1 is consistent with the hypothesized sensory function of these cells. Although we did not do extensive testing of phenotypes regulated by the CVO, we did find that Phr1 ␤-Gal/␤-Gal mice tolerated water deprivation and did not manifest abnormalities of body mass. Thus, the functional role of PHR1 in these cells is uncertain.
Finally, our Phr1 expression studies are also of interest for the cells in which we found no expression. Others have suggested, on the basis of in situ hybridization studies, that Phr1 is expressed in retinal pigment epithelium and oligodendrocytes and Schwann cells (22) . We failed to find Phr1 expression in these cells. It may be that the in situ hybridization observed by Krappa et al. was to transcripts related to, but distinct from, Phr1.
Despite the specific and abundant expression of Phr1 in the primary sensory neurons, we did not detect an abnormal phenotype in the Phr1 ␤-Gal/␤-Gal mice. Expression of a related protein whose function overlaps with that of PHR1 could explain this apparent lack of phenotype. PHR2, a PHR1 homolog identified by Krappa et al. and designated EVT2 by them, is an obvious candidate for a functionally redundant suppressor of phenotype for a Phr1 null allele (22) . Overall, PHR2 has 38.4% amino acid identity and 57.6% amino acid similarity to PHR1 isoform 3 (Fig. 8) . In the PH domain and the C-terminal transmembrane domain, the resemblance was much higher, with 50% identity and 73% similarity in the PH domain and 61% identity and 68% similarity in the C-terminal transmembrane domain. Phr2 is expressed in many tissues, including brain, retina, heart, kidney, lung, muscle, and peripheral nerve, with the highest levels in brain and retina (22) . We found that Phr2 is also expressed in OE (Fig. 8) . Although these studies show that Phr2 is expressed in many of the same tissues as Phr1, they do not confirm that the two proteins are expressed in precisely the same cells. Moreover, in our Phr1 ␤-Gal/␤-Gal mice, the amounts of Phr2 mRNA were only modestly increased (ϳ25%) over controls (Fig. 8) , suggesting that PHR2 does not compensate for the lack of PHR1. An unequivocal understanding of the role of PHR2 in mice lacking PHR1 will require creation and characterization of Phr2 mutant and Phr1/Phr2 double mutant mice.
APPENDIX
Expression of Phr1 in the tongue and spinal cord as shown by ␤-Gal staining in mice homozygous to the targeted allele is shown in Fig. A1 .
Note the staining of an occasional taste bud and staining of neuromuscular spindles in muscle fibers of the tongue.
The remaining figures show various aspects of the phenotypes of mice homozygous for the targeted disruption of Phr1. ERG in intact 6-monthold mice and in single rod photoreceptors isolated from 2-month-old animals is shown in Fig. A2 . Figure A3 shows studies to evaluate olfactory function in Phr1 ␤-Gal/␤-Gal animals, including immunohistochemical localization in OE and EOGs in response to a variety of odorants. Figure A4 has 38% amino acid identity with murine PHR1 isoform 3. The similarity is much higher in certain domains. For example, the N-terminal PH domains of PHR1 and PHR2 are 50% identical and 73% similar. Their C-terminal transmembrane domains (TMD) are 61% identical and 68% similar. Boxed bold or shaded letters are identical residues in three or four sequences, respectively. Boxed-only letters are similar residues. (B) Northern blot analysis of total cellular RNA (5 g/lane) harvested from the indicated tissues from Phr1 ␤-Gal/␤-Gal and Phr1 ϩ/ϩ mice. A 3.2-kb Phr2 transcript is present in RNA from retina, OE, and brain, with levels in the following order: retina Ͼ brain Ͼ OE. 
